Actavis to Acquire Allergan for $66 Billion
November 17, 2014 at 09:17 AM EST
Actavis said it would acquire Allergan for a stock and cash deal totaling about $66 billion, or $219 per share, creating a top 10 global pharma company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.